NeoVirTech
Founded in 2014, NeoVirTech (NVT) is one of Europe's leading viral imaging and antiviral discovery companies.
Transfer project
As part of its support, Toulouse Tech Transfer mobilised all its business skills. Involved throughout the maturation process, TTT identified and safeguarded the invention with the help of its intellectual property department, in particular through patents. The SATT has also invested in the technical development and TRL ramp-up.
The company
The aim of NeoVirTech is to provide researchers with state-of-the-art virology tests using innovative image-based reading.
Virology tests require expertise, know-how and regulatory facilities involving laboratory containment that can be difficult to access in conventional laboratories. In addition, conventional virology methods are expensive, time-consuming and slow down the discovery process.
NeoVirTech has developed an ever-expanding catalogue of autofluorescent viruses and viral vectors for direct imaging of the effect of antiviral drug candidates or disinfection procedures in the fields of human health, animal health, and biodefence.